123 related articles for article (PubMed ID: 2979250)
1. Effect of low-dose omeprazole on gastric acid secretion in duodenal ulcer patients.
McLauchlan G; Crean GP; McColl KE
Aliment Pharmacol Ther; 1988 Jun; 2(3):263-8. PubMed ID: 2979250
[TBL] [Abstract][Full Text] [Related]
2. Comparison of once-daily intravenous and oral omeprazole on pentagastrin-stimulated acid secretion in duodenal ulcer patients.
Cederberg C; Lind T; Röhss K; Olbe L
Digestion; 1992; 53(3-4):171-8. PubMed ID: 1291405
[TBL] [Abstract][Full Text] [Related]
3. Reduction of gastric acid secretion by 10 mg and 30 mg omeprazole once daily.
Nielsen AM; Stenderup J; Wandall JH; Bonnevie O
Scand J Gastroenterol; 1985 Dec; 20(10):1236-8. PubMed ID: 3912960
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.
Lind T; Cederberg C; Olausson M; Olbe L
Eur J Clin Pharmacol; 1991; 40(6):557-60. PubMed ID: 1884735
[TBL] [Abstract][Full Text] [Related]
5. Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S; Zak J
Am J Med; 1991 Aug; 91(2A):91S-94S. PubMed ID: 1882910
[TBL] [Abstract][Full Text] [Related]
6. Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Perilli D; Vassallo A; Zambotti A; Mansi C; Celle G
Dig Dis Sci; 1994 Jul; 39(7):1473-82. PubMed ID: 8026259
[TBL] [Abstract][Full Text] [Related]
7. [Omeprazole in peptic ulceration: acid inhibition and endoscopic healing].
Chen SP; Mai CR; Ke MY
Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):720-1, 767. PubMed ID: 2636088
[TBL] [Abstract][Full Text] [Related]
8. Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer.
Howden CW; Derodra JK; Burget DW; Hunt RH
Hepatogastroenterology; 1986 Dec; 33(6):267-70. PubMed ID: 3804185
[TBL] [Abstract][Full Text] [Related]
9. Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action.
Festen HP; Tuynman HA; Den Hollander W; Meuwissen SG
Aliment Pharmacol Ther; 1989 Aug; 3(4):375-9. PubMed ID: 2518851
[TBL] [Abstract][Full Text] [Related]
10. A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer.
Vigneri S; Savarino V; Mela GS; Termini R; Di Mario F; Pantalena M; Zentilin P; Muratore F; Scialabba A; Badalamenti S
Scand J Gastroenterol; 1994 Jun; 29(6):488-92. PubMed ID: 8079104
[TBL] [Abstract][Full Text] [Related]
11. Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.
Thompson JN; Barr JA; Collier N; Spencer J; Bush A; Cope L; Gribble RJ; Baron JH
Gut; 1985 Oct; 26(10):1018-24. PubMed ID: 3932137
[TBL] [Abstract][Full Text] [Related]
12. Effects of omeprazole in duodenal ulcer patients.
Karvonen AL; Keyriläinen O; Uusitalo A; Salaspuro M; Tarpila S; Andrén K; Helander HF
Scand J Gastroenterol; 1986 May; 21(4):449-54. PubMed ID: 3523740
[TBL] [Abstract][Full Text] [Related]
13. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Bianchi Porro G
Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586
[TBL] [Abstract][Full Text] [Related]
14. Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients.
Hewson EG; Yeomans ND; Angus PW; Shulkes A; Brook CW; Sewell RB; Smallwood RA
Gut; 1988 Dec; 29(12):1715-20. PubMed ID: 3220312
[TBL] [Abstract][Full Text] [Related]
15. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
Bytzer P; Aalykke C; Rune S; Weywadt L; Gjørup T; Eriksen J; Bonnevie O; Bekker C; Kromann-Andersen H; Kjaergaard J; Rask-Madsen J; Vilien M; Hansen J; Justesen T; Vyberg M; Teglbjaerg PS
Scand J Gastroenterol; 2000 Oct; 35(10):1023-32. PubMed ID: 11099054
[TBL] [Abstract][Full Text] [Related]
16. Dose ranging study of lansoprazole, a new proton pump inhibitor, in patients with high gastric acid secretion.
Berlin I; Molinier P; Duchier A; Cournot A; Durrel J; Dellatolas F; Duchier J
Eur J Clin Pharmacol; 1992; 43(2):117-9. PubMed ID: 1425865
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.
Hetzel DJ; Shearman DJ
Br J Clin Pharmacol; 1984 Oct; 18(4):587-90. PubMed ID: 6487498
[TBL] [Abstract][Full Text] [Related]
18. Effect of intermittent weekend therapy with omeprazole on basal and bombesin- and pentagastrin-stimulated gastric acid and serum gastrin.
Crobach LF; Jansen JB; Lamers CB
Scand J Gastroenterol; 1988 May; 23(4):407-12. PubMed ID: 3381063
[TBL] [Abstract][Full Text] [Related]
19. Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects.
Röhss K; Wilder-Smith C; Kilhamn J; Fjellman M; Lind T
Int J Clin Pharmacol Ther; 2007 Jun; 45(6):345-54. PubMed ID: 17595892
[TBL] [Abstract][Full Text] [Related]
20. Acid blockade by omeprazole or ICI 162846 in a chronic duodenal ulcer model.
Gompertz RH; Man WK; Li SK; Spencer J; Baron JH; Michalowski AS
Agents Actions; 1991 May; 33(1-2):161-3. PubMed ID: 1716826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
